Creo Medical Limited (CREO.L)
GBp 16.25
(-5.8%)
GBp 16.25
(-5.8%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 30.8 Million | 27.16 Million | 25.16 Million | 9.42 Million | 13.47 Thousand | - |
| Cost of Revenue | 15.5 Million | 17.16 Million | 16.13 Million | 6.99 Million | 650.24 Thousand | 331.61 Thousand |
| Gross Profit | 15.3 Million | 10 Million | 9.02 Million | 2.43 Million | -636.77 Thousand | -331.61 Thousand |
| Operating Expenses | 40.1 Million | 40.81 Million | 38.98 Million | 25.83 Million | 18.38 Million | 11.61 Million |
| Selling, General and Administrative Expenses | 40.5 Million | 27.28 Million | 26.11 Million | 15.63 Million | 10.23 Million | 6.37 Million |
| Research and Development Expenses | 11.9 Million | 13.52 Million | 12.86 Million | 10.19 Million | 8.14 Million | 5.23 Million |
| Other Expenses | -12.3 Million | - | - | - | - | - |
| Cost and Expenses | 55.6 Million | 57.97 Million | 55.12 Million | 32.82 Million | 19.03 Million | 11.94 Million |
| Operating Income | -24.8 Million | -30.8 Million | -29.95 Million | -23.39 Million | -19.01 Million | -11.94 Million |
| Interest Expense | 400 Thousand | 248 Thousand | 237 Thousand | 97 Thousand | 14.06 Thousand | 11.16 Thousand |
| Income Tax Expense | -2.8 Million | -4.04 Million | -5.74 Million | -3.14 Million | -2.7 Million | -1.84 Million |
| Earnings before Tax | -24.5 Million | -30.97 Million | -30.33 Million | -23.46 Million | -18.61 Million | -11.71 Million |
| Net Income | -21.7 Million | -26.93 Million | -24.59 Million | -20.31 Million | -15.91 Million | -9.87 Million |
| Earnings Per Share Basic | -0.07 | -0.14 | -0.14 | -0.13 | -0.13 | -0.11 |
| Earnings Per Share Diluted | -0.07 | -0.14 | -0.14 | -0.13 | -0.13 | -0.11 |
| Weighted Average Shares Outstanding | 313 Million | 187.89 Million | 170.38 Million | 161.57 Million | 125.84 Million | 93.78 Million |
| Weighted Average Shares Outstanding (Diluted) | 313 Million | 187.89 Million | 170.38 Million | 161.57 Million | 125.84 Million | 93.78 Million |
| Gross Margin | 0.50 | 0.37 | 0.36 | 0.26 | -47.26 | - |
| EBIT Margin | -0.67 | -1.02 | -1.09 | -2.31 | -1363.95 | - |
| Profit Margin | -0.70 | -0.99 | -0.98 | -2.15 | -1180.97 | - |
| EBITDA | -20.7 Million | -27.61 Million | -27.54 Million | -21.76 Million | -17.95 Million | -11.37 Million |
| Earnings Before Tax Margin | -0.81 | -1.13 | -1.19 | -2.48 | -1411.58 | - |
| Breakdown | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Revenue | 15.2 Million | 30.8 Million | 15.1 Million | 15.7 Million | 27.16 Million | 13.53 Million |
| Cost of Revenue | 8 Million | 18.9 Million | 7.3 Million | 9.9 Million | 17.16 Million | 8.62 Million |
| Gross Profit | 7.2 Million | 11.9 Million | 7.8 Million | 5.8 Million | 10 Million | 4.9 Million |
| Operating Expenses | 20.9 Million | 37.1 Million | 19.2 Million | 19.2 Million | 40.81 Million | 19.75 Million |
| Selling, General and Administrative Expenses | 20.8 Million | - | 19.6 Million | 19.2 Million | - | 13.72 Million |
| Research and Development Expenses | - | - | 11.9 Million | - | - | 6.02 Million |
| Other Expenses | 100 Thousand | - | -12.3 Million | - | - | - |
| Cost and Expenses | 28.9 Million | 56 Million | 26.5 Million | 29.1 Million | 57.97 Million | 28.37 Million |
| Operating Income | -13.7 Million | -25.2 Million | -11.4 Million | -13.4 Million | -30.8 Million | -14.84 Million |
| Interest Expense | - | 400 Thousand | 300 Thousand | 100 Thousand | 248 Thousand | 208 Thousand |
| Income Tax Expense | 1.5 Million | -2.8 Million | 1.2 Million | -1.6 Million | -4.04 Million | -1.47 Million |
| Earnings before Tax | -13.8 Million | -24.5 Million | -11.3 Million | -13.2 Million | -30.97 Million | -14.97 Million |
| Net Income | -12.3 Million | -21.7 Million | -10.1 Million | -11.6 Million | -26.93 Million | -13.5 Million |
| Earnings Per Share Basic | -0.03 | - | -0.03 | -0.04 | - | -0.07 |
| Earnings Per Share Diluted | -0.03 | - | -0.03 | -0.04 | - | -0.07 |
| Weighted Average Shares Outstanding | 361.66 Million | 313 Million | 359.53 Million | 266.48 Million | 187.89 Million | 187.93 Million |
| Weighted Average Shares Outstanding (Diluted) | 361.66 Million | 313 Million | 359.52 Million | 266.48 Million | 187.89 Million | 187.93 Million |
| Gross Margin | 0.47 | 0.39 | 0.52 | 0.37 | 0.37 | 0.36 |
| EBIT Margin | -0.78 | - | -0.70 | -0.75 | - | -0.97 |
| Profit Margin | -0.81 | -0.70 | -0.67 | -0.74 | -0.99 | -1.00 |
| EBITDA | -11.8 Million | - | -10.5 Million | -11.7 Million | - | -13.18 Million |
| Earnings Before Tax Margin | -0.90 | -0.82 | -0.75 | -0.85 | -1.13 | -1.10 |
2208
AAF
3858
CLH
POLR
8431